Mark Chappell

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Jessup Jewell A; Westwood Brian M; Chappell Mark C; Groban Leanne
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
Lindsey Sarah Hoffmann; Cohen Jonathan A; Brosnihan K Bridget; Gallagher Patricia E; Chappell Mark C
Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats.
Isa Katsunori; García-Espinosa Maria Antonia; Arnold Amy C; Pirro Nancy T; Tommasi Ellen N; Ganten Detlev; Chappell Mark C; Ferrario Carlos M; Diz Debra I
Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mark Chappell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Jessup Jewell A; Westwood Brian M; Chappell Mark C; Groban Leanne
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
Therapeutic advances in cardiovascular disease 2009;3(4):245-57.
2009: Lindsey Sarah Hoffmann; Cohen Jonathan A; Brosnihan K Bridget; Gallagher Patricia E; Chappell Mark C
Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats.
Endocrinology 2009;150(8):3753-8.
2009: Isa Katsunori; García-Espinosa Maria Antonia; Arnold Amy C; Pirro Nancy T; Tommasi Ellen N; Ganten Detlev; Chappell Mark C; Ferrario Carlos M; Diz Debra I
Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;297(1):R111-5.
2009: Pendergrass Karl D; Gwathmey Tanya M; Michalek Ryan D; Grayson Jason M; Chappell Mark C
The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus.
Biochemical and biophysical research communications 2009;384(2):149-54.
2009: Gwathmey Tanya M; Shaltout Hossam A; Pendergrass Karl D; Pirro Nancy T; Figueroa Jorge P; Rose James C; Diz Debra I; Chappell Mark C
Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production.
American journal of physiology. Renal physiology 2009;296(6):F1484-93.
2009: Ferrario Carlos M; Varagic Jasmina; Habibi Javad; Nagata Sayaka; Kato Johji; Chappell Mark C; Trask Aaron J; Kitamura Kazuo; Whaley-Connell Adam; Sowers James R
Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.
American journal of physiology. Heart and circulatory physiology 2009;296(4):H1184-92.
2009: Shaltout Hossam A; Figueroa Jorge P; Rose James C; Diz Debra I; Chappell Mark C
Alterations in circulatory and renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 in fetal programmed hypertension.
Hypertension 2009;53(2):404-8.
2008: Kantorowicz Lucia; Valego Nancy K; Tang LiJun; Figueroa Jorge P; Chappell Mark C; Carey Luke C; Rose James C
Plasma and renal renin concentrations in adult sheep after prenatal betamethasone exposure.
Reproductive sciences (Thousand Oaks, Calif.) 2008;15(8):831-8.
2008: Varagic Jasmina; Trask Aaron J; Jessup Jewell A; Chappell Mark C; Ferrario Carlos M
New angiotensins.
Journal of molecular medicine (Berlin, Germany) 2008;86(6):663-71.
2008: Trask Aaron J; Jessup Jewell A; Chappell Mark C; Ferrario Carlos M
Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart.
American journal of physiology. Heart and circulatory physiology 2008;294(5):H2242-7.
2008: Garabelli Paul J; Modrall J Gregory; Penninger Josef M; Ferrario Carlos M; Chappell Mark C
Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.
Experimental physiology 2008;93(5):613-21.
2008: Diz Debra I; Garcia-Espinosa Maria A; Gegick Stephen; Tommasi Ellen N; Ferrario Carlos M; Ann Tallant E; Chappell Mark C; Gallagher Patricia E
Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats.
Experimental physiology 2008;93(5):694-700.
2008: Groban Leanne; Yamaleyeva Liliya M; Westwood Brian M; Houle Timothy T; Lin Marina; Kitzman Dalane W; Chappell Mark C
Progressive diastolic dysfunction in the female mRen(2). Lewis rat: influence of salt and ovarian hormones.
The journals of gerontology. Series A, Biological sciences and medical sciences 2008;63(1):3-11.
2008: Chappell Mark C; Westwood Brian M; Yamaleyeva Liliya M
Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension.
Gender medicine : official journal of the Partnership for Gender-Specific Medicine at Columbia University 2008;5 Suppl A():S65-75.
2008: Benter Ibrahim F; Yousif Mariam H M; Dhaunsi Gursev S; Kaur Jaspal; Chappell Mark C; Diz Debra I
Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.
American journal of nephrology 2008;28(1):25-33.
2007: Chappell Mark C
Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?
Hypertension 2007;50(4):596-9.
2007: Yamaleyeva Liliya M; Pendergrass Karl D; Pirro Nancy T; Gallagher Patricia E; Groban Leanne; Chappell Mark C
Ovariectomy is protective against renal injury in the high-salt-fed older mRen2. Lewis rat.
American journal of physiology. Heart and circulatory physiology 2007;293(4):H2064-71.
2007: Joyner J; Neves L A A; Granger J P; Alexander B T; Merrill D C; Chappell M C; Ferrario C M; Davis W P; Brosnihan K B
Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(1):R169-77.
2007: Trask Aaron J; Averill David B; Ganten Detlev; Chappell Mark C; Ferrario Carlos M
Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
American journal of physiology. Heart and circulatory physiology 2007;292(6):H3019-24.
2007: Yamaleyeva Liliya M; Gallagher Patricia E; Vinsant Sharon; Chappell Mark C
Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2. Lewis rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;292(2):R819-26.
2007: Shaltout Hossam A; Westwood Brian M; Averill David B; Ferrario Carlos M; Figueroa Jorge P; Diz Debra I; Rose James C; Chappell Mark C
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.
American journal of physiology. Renal physiology 2007;292(1):F82-91.
2006: Neves L A A; Chappell M C; Ferrario C M; Gallagher P E; Ganten D; Brosnihan K B
Effect of estrogen on neprilysin expression in uterus and kidney of Sprague-Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats.
Peptides 2006;27(11):2912-8.
2006: Chappell Mark C; Yamaleyeva Liliya M; Westwood Brian M
Estrogen and salt sensitivity in the female mRen(2). Lewis rat.
American journal of physiology. Regulatory, integrative and comparative physiology 2006;291(5):R1557-63.
2006: Jessup Jewell A; Gallagher Patricia E; Averill David B; Brosnihan K Bridget; Tallant E Ann; Chappell Mark C; Ferrario Carlos M
Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
American journal of physiology. Heart and circulatory physiology 2006;291(5):H2166-72.
2006: Pendergrass Karl D; Averill David B; Ferrario Carlos M; Diz Debra I; Chappell Mark C
Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat.
American journal of physiology. Renal physiology 2006;290(6):F1497-506.
2006: Chen Yanfang; Chen Hao; Hoffmann Andrea; Cool David R; Diz Debra I; Chappell Mark C; Chen Alex F; Morris Mariana
Adenovirus-mediated small-interference RNA for in vivo silencing of angiotensin AT1a receptors in mouse brain.
Hypertension 2006;47(2):230-7.
2006: Gallagher Patricia E; Chappell Mark C; Ferrario Carlos M; Tallant E Ann
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
American journal of physiology. Cell physiology 2006;290(2):C420-6.
2006: Groban Leanne; Pailes Nathan A; Bennett Colleen D L; Carter Christy S; Chappell Mark C; Kitzman Dalane W; Sonntag William E
Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats.
The journals of gerontology. Series A, Biological sciences and medical sciences 2006;61(1):28-35.
2005: Ferrario Carlos M; Jessup Jewell; Gallagher Patricia E; Averill David B; Brosnihan K Bridget; Ann Tallant E; Smith Ronald D; Chappell Mark C
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Kidney international 2005;68(5):2189-96.
2005: Brosnihan K Bridget; Neves Liomar A A; Chappell Mark C
Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension?
Hypertension 2005;46(5):1097-9.
2005: Sadjadi Javid; Kramer Gerald L; Yu Chun-Hua; Burress Welborn M; Chappell Mark C; Gregory Modrall J
Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
The Journal of surgical research 2005;127(2):65-9.
2005: Ferrario Carlos M; Jessup Jewell; Chappell Mark C; Averill David B; Brosnihan K Bridget; Tallant E Ann; Diz Debra I; Gallagher Patricia E
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Circulation 2005;111(20):2605-10.
2004: Ferrario C M; Chappell M C
Novel angiotensin peptides.
Cellular and molecular life sciences : CMLS 2004;61(21):2720-7.
2004: Modrall J Gregory; Sadjadi Javid; Brosnihan K Bridget; Gallagher Patricia E; Yu Chun-hua; Kramer Gerald L; Bernstein Kenneth E; Chappell Mark C
Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides.
Hypertension 2004;43(4):849-53.
2004: Chappell Mark C; Modrall J Gregory; Diz Debra I; Ferrario Carlos M
Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation.
Contributions to nephrology 2004;143():77-89.
2003: Averill David B; Ishiyama Yuichiro; Chappell Mark C; Ferrario Carlos M
Cardiac angiotensin-(1-7) in ischemic cardiomyopathy.
Circulation 2003;108(17):2141-6.
2003: Chappell Mark C; Gallagher Patricia E; Averill David B; Ferrario Carlos M; Brosnihan K Bridget
Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat.
Hypertension 2003;42(4):781-6.
2003: Brosnihan K Bridget; Neves Liomar A A; Joyner JaNae; Averill David B; Chappell Mark C; Sarao Renu; Penninger Josef; Ferrario Carlos M
Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy.
Hypertension 2003;42(4):749-53.
2003: Neves Liomar A A; Averill David B; Ferrario Carlos M; Chappell Mark C; Aschner Judy L; Walkup Michael P; Brosnihan K Bridget
Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries.
Peptides 2003;24(3):455-62.
2003: Nakamura Shigefumi; Averill David B; Chappell Mark C; Diz Debra I; Brosnihan K Bridget; Ferrario Carlos M
Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR.
American journal of physiology. Regulatory, integrative and comparative physiology 2003;284(1):R164-73.
2002: Ferrario Carlos M; Averill David B; Brosnihan K Bridget; Chappell Mark C; Iskandar Samy S; Dean Richard H; Diz Debra I
Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.
Kidney international 2002;62(4):1349-57.
2002: Crackower Michael A; Sarao Renu; Oudit Gavin Y; Yagil Chana; Kozieradzki Ivona; Scanga Sam E; Oliveira-dos-Santos Antonio J; da Costa Joan; Zhang Liyong; Pei York; Scholey James; Ferrario Carlos M; Manoukian Armen S; Chappell Mark C; Backx Peter H; Yagil Yoram; Penninger Josef M
Angiotensin-converting enzyme 2 is an essential regulator of heart function.
Nature 2002;417(6891):822-8.
2002: Ferrario Carlos M; Smith Ronald D; Brosnihan Bridget; Chappell Mark C; Campese Vito M; Vesterqvist Ole; Liao Wei-chi; Ruddy Michael C; Grim Clarence E
Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension.
American journal of hypertension 2002;15(6):557-64.
2001: Chappell M C; Diz D I; Gallagher P E
The renin-angiotensin system and the exocrine pancreas.
JOP : Journal of the pancreas 2001;2(1):33-9.
2001: Chappell M C; Allred A J; Ferrario C M
Pathways of angiotensin-(1-7) metabolism in the kidney.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 1():22-6.
2000: Allred A J; Diz D I; Ferrario C M; Chappell M C
Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues.
American journal of physiology. Renal physiology 2000;279(5):F841-50.
2000: Allred A J; Chappell M C; Ferrario C M; Diz D I
Differential actions of renal ischemic injury on the intrarenal angiotensin system.
American journal of physiology. Renal physiology 2000;279(4):F636-45.
2000: Iyer S N; Averill D B; Chappell M C; Yamada K; Allred A J; Ferrario C M
Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats.
Hypertension 2000;36(3):417-22.
2000: Iyer S N; Yamada K; Diz D I; Ferrario C M; Chappell M C
Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
Journal of cardiovascular pharmacology 2000;36(1):109-17.
2000: Strawn W B; Chappell M C; Dean R H; Kivlighn S; Ferrario C M
Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.
Circulation 2000;101(13):1586-93.
2000: Chappell M C; Gomez M N; Pirro N T; Ferrario C M
Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition.
Hypertension 2000;35(1 Pt 2):348-52.
1999: Yamada K; Iyer S N; Chappell M C; Brosnihan K B; Fukuhara M; Ferrario C M
Differential response of angiotensin peptides in the urine of hypertensive animals.
Regulatory peptides 1999;80(1-2):57-66.
1999: Gallagher P E; Li P; Lenhart J R; Chappell M C; Brosnihan K B
Estrogen regulation of angiotensin-converting enzyme mRNA.
Hypertension 1999;33(1 Pt 2):323-8.
1998: Chappell M C; Diz D I; Yunis C; Ferrario C M
Differential actions of angiotensin-(1-7) in the kidney.
Kidney international. Supplement 1998;68():S3-6.
1998: Chappell M C; Iyer S N; Diz D I; Ferrario C M
Antihypertensive effects of angiotensin-(1-7).
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 1998;31(9):1205-12.
1998: Yamada K; Iyer S N; Chappell M C; Ganten D; Ferrario C M
Converting enzyme determines plasma clearance of angiotensin-(1-7).
Hypertension 1998;32(3):496-502.
1998: Ferrario C M; Chappell M C; Dean R H; Iyer S N
Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis.
Journal of the American Society of Nephrology : JASN 1998;9(9):1716-22.
1998: Iyer S N; Chappell M C; Brosnihan K B; Ferrario C M
Role of AT1 and AT2 receptors in the plasma clearance of angiotensin II.
Journal of cardiovascular pharmacology 1998;31(3):464-9.
1998: Ferrario C M; Martell N; Yunis C; Flack J M; Chappell M C; Brosnihan K B; Dean R H; Fernandez A; Novikov S V; Pinillas C; Luque M
Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects.
American journal of hypertension 1998;11(2):137-46.
1998: Iyer S N; Chappell M C; Averill D B; Diz D I; Ferrario C M
Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.
Hypertension 1998;31(2):699-705.
1998: Chappell M C; Pirro N T; Sykes A; Ferrario C M
Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
Hypertension 1998;31(1 Pt 2):362-7.
1998: Iyer S N; Ferrario C M; Chappell M C
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Hypertension 1998;31(1 Pt 2):356-61.
1997: Ferrario C M; Chappell M C; Tallant E A; Brosnihan K B; Diz D I
Counterregulatory actions of angiotensin-(1-7).
Hypertension 1997;30(3 Pt 2):535-41.
1997: Li P; Chappell M C; Ferrario C M; Brosnihan K B
Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Hypertension 1997;29(1 Pt 2):394-400.
1997: Tallant E A; Lu X; Weiss R B; Chappell M C; Ferrario C M
Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor.
Hypertension 1997;29(1 Pt 2):388-93.
1995: Chappell M C; Jacobsen D W; Tallant E A
Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells.
Peptides 1995;16(4):741-7.
1994: Ferrario C M; Chappell M C
A new myocardial conversion of angiotensin I.
Current opinion in cardiology 1994;9(5):520-6.
1992: Chappell M C; Welches W R; Brosnihan K B; Ferrario C M
Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate.
Peptides 1992;13(5):943-6.
1992: Yamamoto K; Chappell M C; Brosnihan K B; Ferrario C M
In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats.
Hypertension 1992;19(6 Pt 2):692-6.
1992: Chappell M C; Diz D I; Jacobsen D W
Pharmacological characterization of angiotensin II binding sites in the canine pancreas.
Peptides 1992;13(2):313-8.
1992: Jaiswal N; Diz D I; Chappell M C; Khosla M C; Ferrario C M
Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors.
Hypertension 1992;19(2 Suppl):II49-55.
1991: Chappell M C; Millsted A; Diz D I; Brosnihan K B; Ferrario C M
Evidence for an intrinsic angiotensin system in the canine pancreas.
Journal of hypertension 1991;9(8):751-9.
1991: Welches W R; Santos R A; Chappell M C; Brosnihan K B; Greene L J; Ferrario C M
Evidence that prolyl endopeptidase participates in the processing of brain angiotensin.
Journal of hypertension 1991;9(7):631-8.
1991: Kohara K; Brosnihan K B; Chappell M C; Khosla M C; Ferrario C M
Angiotensin-(1-7). A member of circulating angiotensin peptides.
Hypertension 1991;17(2):131-8.
1990: Chappell M C; Tallant E A; Brosnihan K B; Ferrario C M
Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line.
Peptides 1990;11(2):375-80.
1989: Chappell M C; Brosnihan K B; Diz D I; Ferrario C M
Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides.
The Journal of biological chemistry 1989;264(28):16518-23.
1988: Brosnihan K B; Schiavone M T; Sprunger A E; Chappell M C; Rizzo M; Ferrario C M
In vivo release of angiotensin II from the rat hypothalamus.
Hypertension 1988;11(2 Pt 2):I158-62.
1988: Santos R A; Brosnihan K B; Chappell M C; Pesquero J; Chernicky C L; Greene L J; Ferrario C M
Converting enzyme activity and angiotensin metabolism in the dog brainstem.
Hypertension 1988;11(2 Pt 2):I153-7.
1987: Chappell M C; Brosnihan K B; Welches W R; Ferrario C M
Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog.
Peptides 1987;8(5):939-42.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mark Chappell

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mark Chappell (preview)

All Publications